"Making Science Computable"
The Covid-19 Knowledge Accelerator is now the Health Evidence Knowledge Accelerator!
Content and support tools for making science computable and facilitating HEvKA projects can be found on the Fast Evidence Interoperability Resources (FEvIR) Platform.
The FEvIR HEvKA Project Page can be found at https://fevir.net/resources/Project/29272 and includes examples of evidence-related resources in current (R5) FHIR format.
Watch 3 minute Lightning Talks From MCBK 2022
Click on the images below for introductory information about HEvKA
Email balper@computablepublishing.com to be added to the HEvKA distribution list (daily email update of HEvKA activities)
Join an expert working group for code system development -- see Invitation to join Expert Working Group.
Join us at any of the meetings listed on the left side of the screen by clicking on the following link:
Join Microsoft Teams Meeting (see meeting schedule below)
We look forward to seeing you there!
Weekly Meeting Schedule
Day | Time (Eastern) | Team |
---|---|---|
Monday | 8-9 am | Project Management Working Group |
Monday | 9-10 am | Setting the SRDR Platform on FHIR WG |
Monday | 10-11 am | Research on FHIR Working Group |
Monday | 2-3 pm | Statistic Standard and Terminology Working Group |
Tuesday | 9-10 am | Measuring the Rate of Scientific Transfer Working Group (SKAF Board Meets Last Tuesday of Month) |
Tuesday | 11am-12 pm | FEvIR Metadata Framework Working Group |
Tuesday | 2-3 pm | Research Design Working Group |
Wednesday | 8-9 am | Knowledge Ecosystem Liaison Working Group |
Thursday | 8-9 am | EBMonFHIR Implementation Guide WG (a CDS EBM sub-WG) |
Thursday | 9-10 am | Computable EBM Tools Development WG |
Thursday | 4-5 pm | Project Management Working Group |
Friday | 8-9 am | GRADE Terminology Working Group Meeting |
Friday | 9-10 am | Risk of Bias Terminology and Tooling Working Group |
Friday | 10-11 am | Communications (Awareness, Scholarly Publications) WG |
Friday | 12-1 pm | Eligibility Criteria Working Group |
You are welcome to join us!
Please email balper@computablepublishing.com with any questions.
For all of the above meetings: Join Microsoft Teams Meeting
+1 929-346-7156 United States, New York City (Toll)
Conference ID: 324 918 025#
Meeting support by Computable Publishing LLC
Schedule and Agenda for the week:
Friday, March 17:
- 8 am Eastern:GRADE Vocabulary Working Group – draft GRADE concept paper
- 9 am Eastern:Risk of Bias Terminology and Tooling Working Group – continue review and addition of terms and definitions to the Scientific Evidence Code System; attention to Reporting Bias terms
- 10 am Eastern:Communications Working Group – draft script for HEvKA update for HL7 Annual Report; review progress on publications, presentations (AMIA, GIN), and website
- 12 pm Eastern:Eligibility Criteria Working Group – introduction for EuroVulcan participants; Cohort Definition Track for May Connectathon
Monday, March 20:
- 8 am Eastern:Project Management – review FHIR Trackers and IG preparations
- 9 am Eastern:Setting the SRDR Platform on FHIR Working Group – review FEvIR: SRDR+ Project Importer
- 10 am Eastern:ResearchOnFHIR Working Group – continue learning about FHIRPath and CQL
- 2 pm Eastern:Statistic Standard and Terminology – define StatisticalModel Profile and sample size calculation example; Standard Deviation terms for SEVCO
Tuesday, March 21:
- 9 am Eastern:Measuring the Rate of Scientific Knowledge Transfer Working Group – evaluate citation mapping databases
- 12 pm Eastern:FEvIR Metadata Framework Working Group – review Canonical Resource Management Infrastructure (CRMI) Implementation Guide
- 2 pm Eastern:Research Design Working Group – review in-form-for-submission draft article for peer-reviewed publication; SUBMIT if ready
Wednesday, March 22:
- 8 am Eastern:Knowledge Ecosystem Liaison Working Group – determined by participants
Thursday, March 23:
- 8 am Eastern:EBM Implementation Guide Working Group (HL7 CDS EBMonFHIR sub-WG) – Profile development (RiskOfBias)
- 9 am Eastern:Computable EBM Tools Development Working Group – review FEvIR™: Adaptation Builder/Viewer and FEvIR™: EvidenceVariable Builder/Viewer
- 12 pm Eastern:HL7 Biomedical Research and Regulation Work Group - FHIR Representation of Eligibility Criteria for Clinical Trials project
- 1 pm Eastern: HL7 Clinical Decision Support sub-Work Group (LHS Connectathon Coordination) - Cohort Definition Track for May Connectathon
- 4 pm Eastern:Project Management – prepare weekly agenda
Friday, March 24:
- 8 am Eastern:GRADE Vocabulary Working Group – Continue GRADE Vocabulary Development Methods Protocol
- 9 am Eastern:Risk of Bias Terminology and Tooling Working Group – continue review and addition of terms and definitions to the Scientific Evidence Code System; attention to Reporting Bias terms
- 10 am Eastern:Communications Working Group – review progress on publications, presentations, and website
- 12 pm Eastern:Eligibility Criteria Working Group – review of Characteristic Resource and Cohort Definition Track for May Connectathon
Participation Opportunities
See an Example of a JSON FHIR Resource
- EXAMPLES showcasing current FHIR format include:
- Evidence Resource (meta-analysis finding) at https://fevir.net/resources/Evidence/55, corresponding Citation Resource at https://fevir.net/resources/Citation/58
- Evidence Resource (randomized trial finding) at https://fevir.net/resources/Evidence/7637, corresponding Citation Resource at https://fevir.net/resources/Citation/7638
- EvidenceReport Resource (“COKA-EBM Clinical Outcomes in ACTT-1 Remdesivir RCT EvidenceReport”) at https://fevir.net/resources/EvidenceReport/156 fully supported with 9 Evidence Resources, 7 EvidenceVariable Resources, 2 Group Resources, and 1 ActivityDefinition Resource
- EvidenceReport Resource (“Anticoagulation for Non-critically ill COVID-19 Multiplatform RCT EvidenceReport”) at https://fevir.net/resources/EvidenceReport/18816
- EvidenceReport Resource (“Anticoagulation for Non-critically ill COVID-19 Individual RCTs Table EvidenceReport”) at https://fevir.net/resources/EvidenceReport/18831
- EvidenceReport Resource (“Anticoagulation for Non-critically ill COVID-19 Summary of Findings from RCTs Table EvidenceReport”) at https://fevir.net/resources/EvidenceReport/18881